​

Arcadia Biosciences (RKDA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

RKDA Stock Forecast

Arcadia Biosciences (RKDA) stock forecast, based on 1 Wall Street analysts, predicts a 12-month average price target of $6.00, with a high of $6.00 and a low of $6.00. This represents a 15.61% increase from the last price of $5.19.

High: $6 Avg: $6 Low: $6 Last Closed Price: $5.19

RKDA Stock Rating

Arcadia Biosciences stock's rating consensus is Buy, based on 1 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 1 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 1 0 1 Strong Sell Sell Hold Buy Strong Buy

RKDA Forecast vs Benchmarks

TypeNameUpside
StockArcadia Biosciences15.61%
SectorBasic Materials Stocks 18.06%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$6.00
Last Closing Price$5.19$5.19$5.19
Upside/Downside--15.61%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 2511---2
Dec, 2411---2
Nov, 24111--3
Oct, 24121--4
Sep, 24-21--3
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 23, 2024Raghuram SelvarajuH.C. Wainwright$6.00$2.78115.83%15.61%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
May 23, 2024H.C. WainwrightBuyBuyhold

Financial Forecast

EPS Forecast

$-90 $-72 $-54 $-36 $-18 $0 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-24.20$-30.33$-26.05$-0.01---
Avg Forecast$-85.20$-23.60$-26.40$-9.73$-1.10$-2.82$-2.19
High Forecast$-86.04$-23.83$-26.49$-9.73$-1.10$-2.82$-2.19
Low Forecast$-84.36$-23.37$-26.31$-9.73$-1.10$-2.82$-2.19
Surprise %-71.60%28.52%-1.33%-99.90%---

Revenue Forecast

$2M $4M $6M $8M $10M $12M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$8.03M$6.78M$9.96M$5.33M---
Avg Forecast$2.16M$7.94M$11.00M$6.25M$4.98M$6.50M$7.90M
High Forecast$2.14M$7.88M$10.97M$6.25M$4.98M$6.50M$7.90M
Low Forecast$2.18M$8.00M$11.03M$6.25M$4.98M$6.50M$7.90M
Surprise %271.94%-14.62%-9.49%-14.72%---

Net Income Forecast

$-150M $-120M $-90M $-60M $-30M $0 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-6.03M$-16.13M$-15.61M$-13.98M---
Avg Forecast$-105.39M$-29.19M$-32.66M$-12.03M$-1.36M$-3.49M$-2.71M
High Forecast$-106.43M$-29.48M$-32.77M$-12.03M$-1.36M$-3.49M$-2.71M
Low Forecast$-104.35M$-28.90M$-32.54M$-12.03M$-1.36M$-3.49M$-2.71M
Surprise %-94.28%-44.73%-52.19%16.23%---

RKDA Forecast FAQ

Is Arcadia Biosciences stock a buy?

Arcadia Biosciences stock has a consensus rating of Buy, based on 1 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 1 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Arcadia Biosciences is a favorable investment for most analysts.

What is Arcadia Biosciences's price target?

Arcadia Biosciences's price target, set by 1 Wall Street analysts, averages $6 over the next 12 months. The price target range spans from $6 at the low end to $6 at the high end, suggesting a potential 15.61% change from the previous close price of $5.19.

How does Arcadia Biosciences stock forecast compare to the average forecast of its sector, industry, and investment themes?

Arcadia Biosciences stock forecast shows a 15.61% upside, underperforming the average forecast for the basic materials stocks sector (18.06%).

What is the breakdown of analyst ratings for Arcadia Biosciences over the past three months?

  • January 2025: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 33.33% Strong Buy, 33.33% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.

What is Arcadia Biosciences’s EPS forecast?

Arcadia Biosciences's average annual EPS forecast for its fiscal year ending in December is -1.1 for 2024, a 10900.00% increase from the reported $-0.01 in 2023. The prediction for 2025 is $-2.82, and $-2.19 for 2026.

What is Arcadia Biosciences’s revenue forecast?

Arcadia Biosciences's average annual revenue forecast for its fiscal year ending in December is $4.98M for 2024, a -6.57% decrease from the reported $5.33M in 2023. The forecast for 2025 is $6.5M, and $7.9M for 2026.

What is Arcadia Biosciences’s net income forecast?

For its fiscal year ending in December, Arcadia Biosciences's average annual net income forecast is $-1.361M for 2024, reflecting a -90.27% decrease from the reported $-13.981M in 2023. The projection for 2025 is $-3.488M, and $-2.709M for 2026.